semaglutide side effect legal team in louisiana glp-1 attorney lawyer law firm The next frontier litigation louisiana semaglutide gastrointestinal obstruction law – semaglutide diarrhea in – semaglutide gastric intestinal obstruction legal

GLP = glucagon-like peptide

Combination Therapy When single-agent GLP-1 therapy reaches a plateau, providers may consider switching to a dual-mechanism agent (like tirzepatide) rather than adding semaglutide

Notice Information: Warning 27 February 2009

Mol Plant Microbe Interact 2003;16:567-79

Starting January 1, 2026, these medications will no longer be covered for weight loss or weight loss-related indications: Ozempic Rybelsus Mounjaro Victoza Byeta Bydureon Trulicity Ensuring Continuation of Therapy If you are currently prescribed any GLP-1 medication for an approved indication, it is important to ensure your prescriber includes the appropriate diagnosis code (ICD-10) when submitting your prescription